Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Bone marrow culture for cancer Institute of Human Genetics Foundation for Research in Genetics and Endocrinology India | 4 | 24 |
|
Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center United States | 8 | 23 |
|
Adaptive Biotechnologies United States | 5 | 3 |
|
PathGroup United States | 3 | 4 |
|
T-Cell Gene Rearrangement (beta+gamma) PathGroup United States | 5 | 2 |
|
Comprehensive HemeComplete Profile with IGH Somatic Hypermutation PathGroup United States | 13 | 161 |
|
B-Cell Gene Rearrangement, ATM and TP53 Mutation Analysis PathGroup United States | 9 | 3 |
|
PathGroup United States | 23 | 160 |
|
B-Cell and T-Cell Gene Rearrangement PathGroup United States | 5 | 3 |
|
FISH, Chronic Lymphocytic Leukemia (CLL) Panel IU Genetic Testing Laboratories Indiana University School of Medicine United States | 1 | 4 |
|
Neoplasia Chromosomal Microarray Analysis Clinical Genomics Laboratory Laboratory for Precision Diagnostics, University of Washington United States | 15 | 1 |
|
Medulloblastoma , Chronic lymphocytic leukemia (detetion of somatic mutations of TP53 gene) CGC Genetics Unilabs Portugal | 2 | 1 |
|
Detection by FISH of BCL6 (3q27) rearrangements CGC Genetics Unilabs Portugal | 1 | 1 |
|
Detection by FISH of 13q14.3 deletion CGC Genetics Unilabs Portugal | 1 | 1 |
|
Detection by FISH of IGH (14q32) rearrangements CGC Genetics Unilabs Portugal | 1 | 1 |
|
OncoFISH for CLL (13q-, 11q-, 17p-, +12) CGC Genetics Unilabs Portugal | 1 | 1 |
|
OncoFISH for CLL (13q-, 11q-, 17p-, +12, IGH) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Detection by FISH of t(11;14) IGH/CCND1 CGC Genetics Unilabs Portugal | 1 | 1 |
|
Detection by FISH of t(14;18) IGH/BCL2 CGC Genetics Unilabs Portugal | 1 | 1 |
|
Detection by FISH of BCL2 (18q21) rearrangements CGC Genetics Unilabs Portugal | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.